• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕妇标本中的游离胎儿 DNA 可稳定长达 5 天。

Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.

机构信息

Department of Transfusion Medicine, University Medical Center, Göttingen, Germany.

出版信息

Prenat Diagn. 2011 Dec;31(13):1300-4. doi: 10.1002/pd.2889. Epub 2011 Oct 26.

DOI:10.1002/pd.2889
PMID:22030893
Abstract

OBJECTIVE

Before noninvasive prenatal diagnosis on the fetal Rhesus D status (NIPD RhD) can be implemented on a mass-scale, it is crucial to define requirements regarding sample transport. The aim of this study was to determine the relation between the transport time of samples for NIPD and the concentration of fetal DNA in maternal plasma.

METHOD

We analyzed qualitative and quantitative data obtained in a previous study performed with real-time PCR to determine the accuracy of NIPD RhD following two different DNA extraction protocols. The number of days from phlebotomy until freezing of plasma at the study site was recorded and defined as transport time.

RESULTS

NIPD RhD results of 972 specimens were analyzed according to transport time, which varied from a few hours to a maximum of 8 days (median 2 days). No decrease of cell-free fetal DNA was observed in samples with less than 6 days transport time. There was a pivotal trend to higher cycle threshold values in samples with ≥ 6 days transport time compared with those with ≤ 5 days.

CONCLUSION

Because only a few laboratories offer an NIPD RhD service, we suggest a maximal transport time of 5 days from phlebotomy until freezing at the testing laboratory.

摘要

目的

在大规模开展胎儿 RhD 状态的无创性产前诊断(NIPD RhD)之前,明确样本运输的要求至关重要。本研究旨在确定用于 NIPD 的样本运输时间与母体外周血浆中胎儿 DNA 浓度之间的关系。

方法

我们分析了之前使用实时 PCR 进行的一项研究中获得的定性和定量数据,以确定两种不同 DNA 提取方案下 NIPD RhD 的准确性。从采血到研究地点冷冻血浆的天数被记录下来,并定义为运输时间。

结果

根据运输时间分析了 972 份标本的 NIPD RhD 结果,运输时间从数小时到最长 8 天不等(中位数为 2 天)。在运输时间少于 6 天的样本中,未观察到游离胎儿 DNA 的减少。与运输时间≤5 天的样本相比,运输时间≥6 天的样本中循环阈值值有升高的趋势。

结论

由于只有少数实验室提供 NIPD RhD 服务,因此我们建议从采血到检测实验室冷冻的最长运输时间为 5 天。

相似文献

1
Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.孕妇标本中的游离胎儿 DNA 可稳定长达 5 天。
Prenat Diagn. 2011 Dec;31(13):1300-4. doi: 10.1002/pd.2889. Epub 2011 Oct 26.
2
Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.利用实时PCR检测孕妇血浆中胎儿DNA进行无创胎儿RHD基因第7外显子和第10外显子基因分型
Fetal Diagn Ther. 2005 Jul-Aug;20(4):275-80. doi: 10.1159/000085085.
3
RHD genotyping from maternal plasma: guidelines and technical challenges.从母体血浆中进行RHD基因分型:指南与技术挑战
Methods Mol Biol. 2008;444:185-201. doi: 10.1007/978-1-59745-066-9_14.
4
Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.从母体血浆中进行无创胎儿RHD基因分型。使用新开发的游离DNA胎儿RhD检测试剂盒。
Transfus Clin Biol. 2007 Dec;14(6):572-7. doi: 10.1016/j.tracli.2008.01.003. Epub 2008 Mar 28.
5
Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.使用RhD阴性女性的母血血浆对胎儿RhD血型进行产前预测的可靠检测方法。
Prenat Diagn. 2005 Nov;25(11):1040-4. doi: 10.1002/pd.1248.
6
[Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].[基于RhD阴性母亲血浆中胎儿DNA的胎儿RhD血型产前测定——二次发表]
Ugeskr Laeger. 2006 Jun 26;168(26-32):2568-70.
7
[Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma].通过分析母体血浆中游离胎儿DNA对胎儿RhD和性别进行无创产前基因诊断
Arch Argent Pediatr. 2009 Oct;107(5):405-9. doi: 10.1590/S0325-00752009000500006.
8
Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.对致敏孕妇进行非侵入性胎儿 RhD、c、E 和 K 血型基因分型的 7 年临床评估。
BJOG. 2011 Oct;118(11):1340-8. doi: 10.1111/j.1471-0528.2011.03028.x. Epub 2011 Jun 14.
9
Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.采用一种新的多重 RT-PCR assay 对孕妇血浆中的游离胎儿 DNA 进行标准化的无创性胎儿 RHD 和 SRY 检测,使之成为临床常规应用:临床获益和成本节约的结果。
Clin Chim Acta. 2012 Feb 18;413(3-4):490-4. doi: 10.1016/j.cca.2011.11.004. Epub 2011 Nov 27.
10
Diagnostic accuracy of noninvasive polymerase chain reaction testing for the determination of fetal rhesus C, c and E status in early pregnancy.非侵入性聚合酶链反应检测在早期妊娠中确定胎儿 RhC、c 和 E 状态的诊断准确性。
BJOG. 2010 May;117(6):722-9. doi: 10.1111/j.1471-0528.2010.02518.x. Epub 2010 Feb 22.

引用本文的文献

1
Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.推荐用于验证和质量保证的非侵入性产前测试胎儿血型和对欧盟法规下的体外诊断试剂风险分类的影响。
Vox Sang. 2022 Feb;117(2):157-165. doi: 10.1111/vox.13172. Epub 2021 Jun 21.
2
Potential of Next-Generation Sequencing in Noninvasive Fetal Molecular Blood Group Genotyping.下一代测序技术在无创胎儿分子血型基因分型中的应用潜力
Transfus Med Hemother. 2020 Feb;47(1):14-22. doi: 10.1159/000505161. Epub 2020 Jan 20.
3
Determination of Fetal RHD Genotype Including the RHD Pseudogene in Maternal Plasma.
母血中胎儿RHD基因型(包括RHD假基因)的测定
J Clin Lab Anal. 2017 May;31(3). doi: 10.1002/jcla.22052. Epub 2016 Sep 6.
4
The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies.载玻片提取系统卡扣卡改善了有抗体孕妇的无创产前基因分型。
Transfus Med Hemother. 2015 Nov;42(6):379-84. doi: 10.1159/000441542. Epub 2015 Oct 26.
5
Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues.正常妊娠和复杂妊娠中游离DNA的定量:克服生物学和技术问题。
PLoS One. 2014 Jul 2;9(7):e101500. doi: 10.1371/journal.pone.0101500. eCollection 2014.
6
Evaluation of sample stability and automated DNA extraction for fetal sex determination using cell-free fetal DNA in maternal plasma.评估使用母体血浆中的游离胎儿 DNA 进行胎儿性别鉴定的样本稳定性和自动化 DNA 提取。
Biomed Res Int. 2013;2013:195363. doi: 10.1155/2013/195363. Epub 2013 Oct 7.
7
Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD.游离胎儿RHD基因无创产前检测中的分析前条件
PLoS One. 2013 Oct 18;8(10):e76990. doi: 10.1371/journal.pone.0076990. eCollection 2013.
8
Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.可靠的胎儿 RhD 状态鉴定:从母体血浆中 RHD 基因分型。
Transfus Med Hemother. 2013 Feb;40(1):37-43. doi: 10.1159/000345682. Epub 2013 Jan 3.